Subpage Banner

HealthTech Stage

HealthTech Stage

INNOVATION, TECHNOLOGY AND PARTNERSHIP

Vibrant, dynamic and representative of the entire spectrum of the medical device supply chain, the HealthTech Stage is where you'll find all the latest news on hardware, software, materials and services. Take a seat and enjoy this engaging two-day conference and seminar programme.

Loading
10:30
  1. A16
    Tactiq Limited and Maddison Ltd

    Patrick and Alan work for companies which have experience in the successful design and development of wearable systems. They will present some of the challenges and outline strategies for successful wearable product development covering the understanding of user’s needs, mechanical, software and electronics aspects of development

10:50
  1. A16
    Albis

    Today, there is a cornucopia of material options available to the producers of medical or diagnostic devices as well as pharmaceutical packaging who plan on using plastics in their applications. The decision to use plastics is based either on their potential to offer significant advantages over classical materials of construction such as glass or metal in terms of weight savings, design flexibility, transportability or to support changing regulatory requirements associated with their existing materials of construction including inter-plastic replacement. The utilization of plastics supports the societal move from the historic hospital, doctor based palliative treatments to a home, self-administered monitoring and treatment approach where classical materials are simply no longer appropriate in a majority of applications.

    However, not all plastics are created equal! Whether considering the desired physical properties of materials; for example, transparency, stiffness, low temperature impact, weldability, ability to be gamma-sterilized or whether considering the regulatory support package that may be supplied with a material, for example notification of change, the period of that notification, biocompatibility testing on the base material etc, there are a number of key questions that should be asked, and answered, during the material selection process; one aspect is often considered without reference to the other which can create issues. Additionally, plastics are produced by the Chemical industry who have a different ‘raison d’etre’ than their typical Healthcare customers especially considering the lifetime of products. Neither should one fail to consider the new Medical Device (MDR 2017/745) & In Vitro Diagnostic (IVDR 2017/746) Regulations where the control of packaging and device materials will become increasingly critical, so such material knowledge becomes increasingly essential. This presentation, therefore, aims to provide guidance on which key questions should be asked, when and to whom regarding the material performance as well as the regulatory support given with these materials. The benefit is, therefore, to better inform the Healthcare community in order to navigate this complex and crowded space and hence to make better, more sustainable decisions.

11:10
  1. A16
    Medtech centre at TRUSTECH

    The NHS faces two challenges in this century. One challenge is to provide high-quality care with dignity to an ageing population, and another to meet increasing demand from the general-population which has growing expectations for what a modern comprehensive healthcare system should provide. Innovation has a crucial role to play in transforming these challenges, and their respective demands on existing resources, into opportunities which can be met in a sustainable manner. It is a good thing that people are living longer, as long as we can enable senior citizens to live healthy and fulfilled lives. Increased demand for healthcare resources is also a good thing if it is focused on improving health outcomes and is a driver for the healthcare system to develop innovative solutions to currently unmet need.

    This talk will outline why the NHS needs to work more closely with innovators both within and outside of the system and the benefits to both parties. Drawing on some examples taken from over 600 innovations which he has assessed during over 10 years working within innovation in the NHS and 15 years prior to that in the private sector, Dr Paul Hanmer will outline key stages in the development of successful MedTech innovations and strategies for engaging with healthcare professionals, provider organisations and patients.

11:30
12:00
  1. A16
    Ultrapolymers
    Increasingly, manufacturers of medical devices are being faced with a need to replace incumbent phthalate-and plasticizer-based materials. What started as a market trend, is now a real need due to regulatory changes coming into effect. This case study looks at inter-material replacement options for flexible PVC, using flexible tubing as the main example but also looks at application developments beyond this market segment. It addresses the topic from a regulatory, technical and commercial point of view, looks at typical application areas and gives an overview of some alternative polymer choices available in the market.
12:20
  1. A16
    David Schnur Associates

    With a tremendous and growing universe of offerings, medical device companies have an abundance of riches. Investment in the OEM device segment by private equity and public companies has brought a huge range of prototyping, component manufacturing, design and development, and full device manufacturing options to market.

    The speaker will outline selection criteria and share a methodology and decision matrix for evaluating outsourcing at each stage, including some key red flags.

12:40
  1. A16
    Centre for Process Innovation (CPI)
    Developing the next generation of devices to meet the challenges of healthy ageing, personalised medicine, home healthcare and the like requires a partnership between innovators, technologists and clinicians. Companies need a significant body of evidence to support new products whilst sustaining high pre-revenue costs with a slow and fragmented adoption pathway to adoption in the UK, hence the need for a collaborative development approach. Photonics enabled devices can be used as a minimally invasive method to diagnose, monitor and treat patients. Recent advances in the design and performance of light sources (LEDs, lasers), detectors (cameras) and optical systems show great promise for healthcare applications. Meanwhile, innovations in the manufacture of flexible electronic components and systems are opening up new market opportunities afforded by the ability to embed electronics functionality into medical devices or packaging. This talk will illustrate these points with examples taken from CPI’s recent work.
13:00
  1. A16
    eg technology
    Danny Godfrey will use his experience of working with innovators and sitting on various awards committees to talk about how best to prepare your business proposals in order to secure grants.
13:20
  1. A16
14:00
  1. A16
    National Institute for Health Research

    The NIHR is a major UK funder of health research. Part of the work that NIHR does involves working with industry, supporting the life sciences industry to generate clinical evidence for new medical technologies.  There are three main services that NIHR offer to the life sciences industry: Access to research funding, access to expertise and collaborators, support for the delivery of trials in the NHS. This talk will provide information on each of these services and how you can access them. 

14:20
  1. A16
    The London BioScience Innovation Centre
    Repair or replacement of many human organs still considers as unmet clinical need, including facial organs, trachea or coronary artery bypass grafts. The key important components in the development of these organs are materials can be used as the scaffold. Commercially there are not many materials to be used for human implantation, this is due to toxicity of material, immunological response or do not have the right physiochemical properties. We have developed a family of nanocomposite materials for biomedical application based on functionalised reduced graphene oxide (FRGO). Graphene considers as a wonder material, it is the strongest material on the planet, super-elastic and conductive. The functionalised GO is nontoxic and antibacterial. We functionalised GO and used it as a building block for nanocomposite materials. The materials can be fabricated to human organs with the 3D printer or other fabrication methodologies. The scaffold from these materials is functionalised with bioactive molecules and stem cells technology, so physiologically simulate the human organs. The data for development of organs using these materials will be presented.
14:40
  1. A16
    Ken Block Consulting
    Software use within medtech is rapidly expanding, and FDA expectations are also changing. Launching innovative new Medtech products on the US market often hinges on a successful FDA software strategy. This session will review the recent draft and final FDA guidance on topics including Clinical Evaluation for Software as a Medical Device, Interoperability, and Clinical/Patient Decision Software. Also discussed will be changes to FDA software policies prompted by the recent 21st Century Cures Act, as well as the new FDA Software Precertification Program.
15:00
  1. A16
    Minnetronix Inc
    The need to improve speed to market and optimize the use of capital is driving more med-tech companies to consider virtual development. But finding the right partner and effectively managing them can be difficult. This presentation will discuss criteria for selecting a virtual product development partner and tools for managing a successful project.
15:20
  1. A16
    Datalink Electronics
    Connected healthcare offers opportunities for a better patient care and lower healthcare cost, by providing ubiquitous means of communication, monitoring, control and automation. However, it poses significant challenges at the device, infrastructure and data management levels. This talk outlines the major components of a connected healthcare platform, details the opportunities and challenges and offers solutions to the issues facing this industry.
10:10
  1. A16
    Worrell Design
    Too often devices are developed with incomplete, biased or unvalidated user inputs—and fail to provide what was truly needed.  Using various techniques, we can objectively generate user needs that cou ...

Thanks to Our Supporters

Platinum Partners


 

Partners

 

Partners

 

Partners

 

Partners

 

Partners

 

2,500

Attendees

29

Seminars

36

Speakers

2

Days

Opening Times

Wednesday 25 April 2018 9:30 - 17:00
Thursday 26 April 2018 9:30 - 15:00

Add Dates to Calendar